Science Explorer Back to mapMap
Discussion
Researcher · Azienda Ospedaliera di Perugia · Italy

Luca Paglialunga

Luca Paglialunga publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

OpenAlex
World rank
#3,333,913
of 7,710,434 ranked researchers
Rank in Italy
#112,918
of 242,206
Works
18
Citations
452
Citations per work
25.1
h-index
9
i10-index 8Top 65% in Oncology
Luca Paglialunga

What does Luca Paglialunga research?

Luca Paglialunga's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 13 works · 72.6% of their workMedicine: 13 works · 72.6% of their workOncology: 7 works · 37.3% of their workPulmonary and Respiratory Medicine: 5 works · 29.4% of their workEpidemiology: 1 works · 3.9% of their workPhysiology: 0 works · 2.0% of their workLife Sciences: 2 works · 13.7% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 13.7% of their workMolecular Biology: 2 works · 9.8% of their workCancer Research: 1 works · 3.9% of their workEverything else: 2 works · 13.7% of their workTHEIR WORKLuca Paglialunga18works
Life Sciences14%Health Sciences73%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1372.6%
    1. Biochemistry, Genetics and Molecular Biology213.7%
  3. Everything else213.7%
  1. 1Oncology37% of their works
  2. 2Pulmonary and Respiratory Medicine29% of their works
  3. 3Molecular Biology10% of their works
  4. 4Cancer Research4% of their works
  5. 5Epidemiology4% of their works
  6. 6Physiology2% of their works

Research topics

Which keywords describe Luca Paglialunga's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade, PD-1 and PD-L1 and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Clinical Trials152 topics
  2. Targeted Therapy152 topics
  3. Chemotherapy134 topics
  4. ALK Inhibitors101 topic
  5. EGFR Mutations101 topic
  6. Immune Checkpoint Blockade71 topic
  7. PD-1 and PD-L171 topic
  8. Genomic Profiles51 topic
  9. Small-Cell Lung Cancer51 topic
  10. Cetuximab31 topic
  11. DNA31 topic
  12. KRAS Mutations31 topic
  13. Topoisomerases31 topic
  14. Breast Cancer21 topic
  15. Fibrosis21 topic
  16. HER221 topic
  17. Idiopathic Pulmonary Fibrosis21 topic
  18. Neuroendocrine Tumors21 topic
  19. Pancreatic Neuroendocrine Tumors21 topic

Where does Luca Paglialunga work?

Luca Paglialunga's main affiliation in the publication record is Azienda Ospedaliera di Perugia, Italy.

How many publications and citations does Luca Paglialunga have?

OpenAlex counts 18 works and 452 citations for Luca Paglialunga, an h-index of 9, ranking #3,333,913 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Luca Paglialunga. Posts are plain text and can be reported.